Breaking News Instant updates and real-time market news.

2020-02-26 14:25:06 CME CME Group $219.91 / +11.6 (+5.57%) 14:25 02/26/20 02/26 14:25 02/26/20 14:25	CME Group call volume above normal and directionally bullish Bullish option flow detected in CME Group with 7,796 calls trading, 5x expected, and implied vol increasing over 1 point to 27.61%. 2/28 weekly 222.5 calls and Jan-21 250 calls are the most active options, with total volume in those strikes near 2,400 contracts. The Put/Call Ratio is 0.19. Earnings are expected on April 29th.	26 Feb 27 Feb
CME CME Group $219.91 / +11.6 (+5.57%) 02/26/20 UBS CME Group upgraded to Buy from Neutral at UBS 01/10/20 Fly Intel: Top five analyst downgrades 01/10/20 Bernstein CME Group downgraded to Market Perform from Outperform at Bernstein 01/10/20 Jefferies Jefferies calls CME, IntercontinentalExchange favorite ideas in Exchanges

2020-02-26 14:25:06

CME

CME Group

$219.91 / +11.6 (+5.57%)

14:25

02/26/20

02/26

14:25

02/26/20

14:25

CME Group call volume above normal and directionally bullish

Bullish option flow detected in CME Group with 7,796 calls trading, 5x expected, and implied vol increasing over 1 point to 27.61%. 2/28 weekly 222.5 calls and Jan-21 250 calls are the most active options, with total volume in those strikes near 2,400 contracts. The Put/Call Ratio is 0.19. Earnings are expected on April 29th.

26
Feb
27
Feb

CME CME Group

$219.91 / +11.6 (+5.57%)

02/26/20 UBS: CME Group upgraded to Buy from Neutral at UBS

01/10/20: Fly Intel: Top five analyst downgrades

01/10/20 Bernstein: CME Group downgraded to Market Perform from Outperform at Bernstein

01/10/20 Jefferies: Jefferies calls CME, IntercontinentalExchange favorite ideas in Exchanges

TODAY'S FREE FLY STORIES

Recommendations	Dine Brands price target raised to $95 from $80 at Barclays » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 DIN Dine Brands $78.83 / -2.795 (-3.42%) Barclays analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands says Applebee's SSS improving roughly 8% QTD from January 03/02/21 Dine Brands sees FY21 capital expenditures $14M 11/17/20 Dine Brands names John Peyton, president and CEO DIN Dine Brands $78.83 / -2.795 (-3.42%) 02/10/21 Deutsche Bank Dine Brands downgraded to Hold from Buy at Deutsche Bank 01/20/21 Wedbush Dine Brands added to Best List Ideas, target raised to $83 at Wedbush 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands reports Q4 adjusted EPS 39c, consensus 67c 10/28/20 Dine Brands reports Q3 EPS 80c, consensus 36c
Hot Stocks	Wendy's sees FY21 cash flows from operations: $310M-$330M » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 WEN Wendy's $21.30 / +0.01 (+0.05%) Sees FY21 CapEx… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:05 Today Wendy's reports Q4 global same-restaurant sales growth 4.7% 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:07 Today Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Recommendations	Ameresco price target raised to $82 from $52 at Canaccord » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 AMRC Ameresco $56.53 / -3.925 (-6.49%) Canaccord analyst Jed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AMRC Ameresco $56.53 / -3.925 (-6.49%) 02/17/21 Ameresco in ESA pact with Nyack Public School District for phase ll renovations 02/05/21 Ameresco partners with Navy for $173M energy project at Norfolk Naval Shipyard 02/02/21 Ameresco, Wells Fargo announce collaboration to develop solar generation assets 11/25/20 Ameresco CEO sells 46.3K shares of common stock AMRC Ameresco $56.53 / -3.925 (-6.49%) 03/02/21 Oppenheimer Ameresco price target raised to $66 from $48 at Oppenheimer 02/09/21 B. Riley Securities Ameresco price target raised to $72 from $50 at B. Riley Securities 01/26/21 Craig-Hallum Ameresco price target raised to $75 from $50 at Craig-Hallum 11/03/20 Craig-Hallum Ameresco price target raised to $50 from $38 at Craig-Hallum AMRC Ameresco $56.53 / -3.925 (-6.49%) 03/01/21 Ameresco sees FY21 EPS $1.18-$1.26, consensus $1.22 03/01/21 Ameresco reports Q4 EPS 47c, consensus 29c 11/02/20 Ameresco raises FY20 adj. EPS view to 94c-$1.00 from 86c-96c 11/02/20 Ameresco reports Q3 adjusted EPS 38c, consensus 25c AMRC Ameresco $56.53 / -3.925 (-6.49%) 03/01/21 Fly Intel: After-Hours Movers 03/09/21 Sustainable Energy & Technology Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	Exicure receives orphan drug designation for cavrotolimod from FDA » 07:07 03/03/21 03/03 07:07 03/03/21 07:07 XCUR Exicure $2.29 / +0.08 (+3.63%) Exicure announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly XCUR Exicure $2.29 / +0.08 (+3.63%) 03/02/21 Exicure's cavrotolimod granted FDA orphan status for merkel cell carcinoma 01/11/21 Exicure granted two FDA fast track designations for cavrotolimod 12/21/20 Exicure announces issuance of two new U.S. patents, and new patent allowance 12/21/20 Exicure announces issuance of two new U.S. patents, and new patent allowance XCUR Exicure $2.29 / +0.08 (+3.63%) 12/18/20 BMO Capital Exicure initiated with an Outperform at BMO Capital XCUR Exicure $2.29 / +0.08 (+3.63%) 11/12/20 Exicure reports Q3 EPS (3c), consensus (9c) XCUR Exicure $2.29 / +0.08 (+3.63%) 12/18/20 Fly Intel: Wall Street's top stories at midday 12/18/20 Fly Intel: Pre-market Movers
Earnings	Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c » 07:07 03/03/21 03/03 07:07 03/03/21 07:07 WEN Wendy's $21.30 / +0.01 (+0.05%) Sees FY21 Global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:05 Today Wendy's reports Q4 global same-restaurant sales growth 4.7% 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's

Hot Stocks	Optinose expects topline results from OPN-019 study in 2Q21 » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 OPTN Optinose $3.92 / -0.085 (-2.12%) In June 2020, the Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects topline results from one XHANCE trial by end of 2021 07:04 Today Optinose sees FY21 XHANCE revenues at least $80M 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects Q1 XHANCE revenues to decrease vs. Q4 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Downgrade	Pollard Banknote downgraded to Hold from Buy at Canaccord » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 PBKOF Pollard Banknote $0.00 / + (+0.00%) Canaccord analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PBKOF Pollard Banknote $0.00 / + (+0.00%) 02/09/21 Raymond James Pollard Banknote initiated with an Outperform at Raymond James 01/04/21 Canaccord Pollard Banknote price target raised to C$40 from C$25 at Canaccord 11/10/20 Canaccord Pollard Banknote price target raised to C$25 from C$21 at Canaccord 05/07/20 Canaccord Pollard Banknote price target raised to C$19 from C$18 at Canaccord
Hot Stocks	Emerson Electric announces first chief sustainability officer. Mike Train » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 EMR Emerson Electric $87.61 / -0.82 (-0.93%) To enhance its focused… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/25/21 Emerson Electric invests in Fluxa 02/17/21 Emerson Electric names Ram Krishnan COO 02/01/21 Emerson Electric CEO Farr to retire Lal Karsanbhai to succeed 12/17/20 Emerson Electric reports November trailing three-month orders down 4% EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/04/21 JPMorgan Emerson Electric price target raised to $95 from $85 at JPMorgan 02/03/21 Citi Emerson Electric price target raised to $98 from $94 at Citi 01/19/21 Goldman Sachs Emerson Electric upgraded to Buy from Neutral at Goldman Sachs 01/15/21 UBS Emerson Electric upgraded to Buy from Neutral at UBS EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/02/21 Emerson Electric sees FY21 EPS $3.70 +/- 10c consensus $3.51 02/02/21 Emerson Electric reports Q1 EPS 83c, consensus 69c 11/03/20 Emerson Electric sees FY21 adjusted EPS $3.45 +/- 5c, consensus $3.42 11/03/20 Emerson Electric reports Q4 adjusted EPS $1.10, consensus 94c EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/04/21 Emerson Electric considering sale of Appleton unit, Bloomberg says
Upgrade	Medexus Pharmaceuticals upgraded to Buy from Hold at Canaccord » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 MEDXF Medexus Pharmaceuticals $0.00 / + (+0.00%) Canaccord analyst Tania… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research MEDXF Medexus Pharmaceuticals $0.00 / + (+0.00%) 02/24/21 Stifel Medexus Pharmaceuticals price target raised to C$17.50 from C$7.25 at Stifel
Hot Stocks	Optinose expects topline results from one XHANCE trial by end of 2021 » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 OPTN Optinose $3.92 / -0.085 (-2.12%) The Company expects… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 07:04 Today Optinose sees FY21 XHANCE revenues at least $80M 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects Q1 XHANCE revenues to decrease vs. Q4 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN

Earnings	Patterson Companies reports Q3 adjusted EPS 58c, consensus 51c » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 PDCO Patterson Companies $32.39 / +0.03 (+0.09%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/30/20 Patterson Companies reports Heartland selects competitor as distribution partner PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/30/20 Piper Sandler Patterson contract loss unexpected but manageable, says Piper Sandler 12/03/20 Barclays Patterson Companies price target raised to $25 from $21 at Barclays 12/02/20 Piper Sandler Patterson Companies price target raised to $33 from $25 at Piper Sandler 11/10/20 Guggenheim Patterson Companies downgraded to Neutral from Buy at Guggenheim PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/02/20 Patterson Companies reports Q2 EPS 63c, consensus 38c 09/03/20 Patterson Companies reports Q1 adj. EPS 33c, consensus 23c PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 09/03/20 Fly Intel: Pre-market Movers 10:00 Today Patterson Companies - PDCO PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/02/20 Early notable gainers among liquid option names on December 2nd 09/24/20 Early notable gainers among liquid option names on September 24th
Hot Stocks	Wendy's reports Q4 global same-restaurant sales growth 4.7% » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 WEN Wendy's $21.30 / +0.01 (+0.05%) Reports Q4 U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 11/04/20 Wendy's raises quarterly dividend 40% to 7c per share WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Earnings	Optinose expects Q1 XHANCE revenues to decrease vs. Q4 » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 OPTN Optinose $3.92 / -0.085 (-2.12%) Revenue consensus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 07:04 Today Optinose sees FY21 XHANCE revenues at least $80M 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Earnings	Calumet Specialty Products reports Q4 EPS (89c), consensus (79c) » 07:04 03/03/21 03/03 07:04 03/03/21 07:04 CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 02/01/21 Calumet Specialty Products to enter into a sale-leaseback transaction 10/05/20 Commercial Vehicle Group names Christopher Bohnert as CFO CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 12/15/20 Wells Fargo Calumet Specialty Products downgraded to Equal Weight at Wells Fargo 12/15/20 Wells Fargo Calumet Specialty downgraded to Equal Weight from Overweight at Wells Fargo CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 11/06/20 Calumet Specialty Products reports Q3 adjusted EPS (49c), consensus (38c) CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 10/01/20 Calumet weighing sale of finished lubricants division, Bloomberg says 09:00 Today Calumet Specialty Products - CLMT
Hot Stocks	Optinose sees FY21 XHANCE revenues at least $80M » 07:04 03/03/21 03/03 07:04 03/03/21 07:04 OPTN Optinose $3.92 / -0.085 (-2.12%) Revenue consensus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN

Upgrade	Richemont upgraded to Overweight from Neutral at JPMorgan » 07:03 03/03/21 03/03 07:03 03/03/21 07:03 CFRUY Richemont $0.00 / + (+0.00%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CFRUY Richemont $0.00 / + (+0.00%) 11/05/20 Farfetch, Alibaba, Richemont form luxury digitization partnership CFRUY Richemont $0.00 / + (+0.00%) 02/17/21 Deutsche Bank Richemont price target raised to CHF 104 from CHF 100 at Deutsche Bank 02/16/21 Morgan Stanley Richemont price target raised to CHF 100 from CHF 87 at Morgan Stanley 02/09/21 Citi Richemont upgraded to Buy from Neutral at Citi 02/02/21 RBC Capital Richemont price target raised to CHF 100 from CHF 95 at RBC Capital
Hot Stocks	Wendy's reports Q4 U.S. systemwide sales growth of 14.2% » 07:03 03/03/21 03/03 07:03 03/03/21 07:03 WEN Wendy's $21.30 / +0.01 (+0.05%) Reports Q4: International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 11/04/20 Wendy's raises quarterly dividend 40% to 7c per share 10/19/20 Wendy's names Kevin Vasconi as Chief Information Officer WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Downgrade	Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold » 07:03 03/03/21 03/03 07:03 03/03/21 07:03 LIVN LivaNova $76.17 / -0.59 (-0.77%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LIVN LivaNova $76.17 / -0.59 (-0.77%) 12/03/20 LivaNova to divest heart valve business to Gyrus for $73M, sees dilution 10/29/20 LivaNova CFO Thad Huston stepping down, Alex Shvartsburg appointed Interim CFO 10/12/20 LivaNova confirms discussions with PrimeStone Capital over past several months 10/12/20 PrimeStone Capital sends letter to LivaNova, says shares reach $100 LIVN LivaNova $76.17 / -0.59 (-0.77%) 05:24 Today Berenberg LivaNova downgraded to Hold from Buy at Berenberg 02/24/21 Piper Sandler LivaNova price target raised to $81 from $73 at Piper Sandler 02/03/21 Piper Sandler Piper says pending epilepsy drug deal 'bears monitoring" by LivaNova holders 01/12/21 Piper Sandler LivaNova price target raised to $73 from $70 at Piper Sandler LIVN LivaNova $76.17 / -0.59 (-0.77%) 02/24/21 LivaNova sees 2021 adjusted EPS $1.40-$1.90, consensus $1.98 02/24/21 LivaNova reports Q4 adjusted EPS 71c, consensus 66c 10/29/20 LivaNova still sees FY20 adjusted EPS $1.15-$1.35, consensus $1.18 10/29/20 LivaNova reports Q3 adjusted EPS 38c, consensus 20c
Earnings	Optinose reports Q4 EPS (46c), consensus (46c) » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 OPTN Optinose $3.92 / -0.085 (-2.12%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Upgrade	Hermes upgraded to Neutral from Underweight at JPMorgan » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 HESAY Hermes $0.00 / + (+0.00%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HESAY Hermes $0.00 / + (+0.00%) 02/23/21 UBS Hermes price target raised to EUR 1,062 from EUR 924 at UBS 02/22/21 Morgan Stanley Hermes price target raised to EUR 945 from EUR 860 at Morgan Stanley 02/22/21 JPMorgan Hermes price target raised to EUR 755 from EUR 635 at JPMorgan 02/22/21 Deutsche Bank Hermes price target raised to EUR 700 from EUR 600 at Deutsche Bank

General news	MBA Mortgage Applications Composite Index data reported » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 Week of 2/26 MBA Mortgage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	CECO Environmental reports Q4 non-GAAP EPS 16c, consensus 10c » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 CECE CECO Environmental $8.21 / -0.12 (-1.44%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings Events CECE CECO Environmental $8.21 / -0.12 (-1.44%) 11/04/20 CECO Environmental reports Q3 non-GAAP EPS 11c, consensus 11c 03/15/21 33rd Annual Roth Virtual Conference 08:30 Today CECO Environmental - CECE
Syndicate	Stratasys 6.897M share Spot Secondary priced at $29.00 » 07:01 03/03/21 03/03 07:01 03/03/21 07:01 SSYS Stratasys $32.27 / -4.12 (-11.32%) The deal range was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/01/21 Stratasys expects Q1 revenue to track similarly to 1Q20 02/18/21 Stratasys acquires U.K.-based RP Support Ltd., terms not stated 02/18/21 Stratasys acquires RPS, provider of best-in-class' stereolithography 3D printers 12/09/20 Stratasys to acquire Origin for total consideration of up to $100M SSYS Stratasys $32.27 / -4.12 (-11.32%) 01/19/21 Stifel Stratasys initiated with a Buy at Stifel 01/15/21 JPMorgan Stratasys downgraded to Underweight from Neutral at JPMorgan 10/09/20 Berenberg Stratasys initiated with a Buy at Berenberg 09/24/20 Fly Intel: Top five analyst downgrades SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/01/21 Stratasys reports Q4 EPS 13c, consensus 0c 11/12/20 Stratasys reports Q3 non-GAAP EPS (5c), consensus (7c) 03 Mar SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/02/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: Pre-market Movers SSYS Stratasys $32.27 / -4.12 (-11.32%) 02/25/21 Stratasys call volume above normal and directionally bullish 01/07/21 Stratasys call volume above normal and directionally bullish 12/17/20 Stratasys call volume above normal and directionally bullish
Initiation	LVMH resumed with Overweight, named top idea at JPMorgan » 07:01 03/03/21 03/03 07:01 03/03/21 07:01 LVMUY LVMH $0.00 / + (+0.00%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $0.00 / + (+0.00%) 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share 10/21/20 Coty appoints Isabelle Bonfanti as CCO, Luxury, Jean-Denis Mariani as CDO LVMUY LVMH $0.00 / + (+0.00%) 02/16/21 Morgan Stanley LVMH price target raised to $600 from $555 at Morgan Stanley 02/09/21 RBC Capital LVMH price target raised to EUR 600 from EUR 530 at RBC Capital 02/02/21 Berenberg LVMH initiated with a Buy at Berenberg 02/01/21 Credit Suisse LVMH price target raised to EUR 540 from EUR 520 at Credit Suisse LVMUY LVMH $0.00 / + (+0.00%) 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $0.00 / + (+0.00%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $0.00 / + (+0.00%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 09/09/20 Fly Intel: Wall Street's top stories for Wednesday 09/09/20 Fly Intel: Wall Street's top stories at midday 09/09/20 Fly Intel: Pre-market Movers
Earnings	Wendy's reports Q4 adjusted EPS 17c, consensus 18c » 07:00 03/03/21 03/03 07:00 03/03/21 07:00 WEN Wendy's $21.30 / +0.01 (+0.05%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 11/04/20 Wendy's raises quarterly dividend 40% to 7c per share 10/19/20 Wendy's names Kevin Vasconi as Chief Information Officer WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's

Events

Earnings calls, analyst events, roadshows and more

TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
WEN
Today at 08:30

Wendy's - WEN Conference Calls
TAST
Today at 08:30

Carrols Restaurant - TAST Conference Calls
PASG
Today at 08:30

Passage Bio - PASG Conference Calls
CECE
Today at 08:30

CECO Environmental - CECE Conference Calls
SBBP
Today at 08:30

Strongbridge Biopharma - SBBP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

CME Group call volume above normal and directionally bullish

TODAY'S FREE FLY STORIES

Get Full Fly Access